Skip to main content
Treating multi drug resistant TB and HIV/AIDS in Manipur, India

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines.

During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in developed countries, remarkable progress was being made in the field of health. Two decades on, medicines in developing countries are still either too expensive, aren't suitable to be used in many of the contexts in which we work (for example, in hot, humid conditions or where there's a lack of electricity), or simply don't exist for the diseases we need to treat.

In 1999, we launched the Campaign for Access to Essential Medicines, now known as the Access Campaign. Its mission focuses on three areas: overcoming barriers to access to essential medicines, stimulating research and development for neglected diseases, promoting health exceptions to global trade agreements.

In 2003, MSF joined several research institutes, including the Institut Pasteur, to create the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organisation engaged in research and development of new treatments for neglected diseases.

 
Website

MSF Access Campaign

msfaccess.org
 
MDR-TB in Mathare, Nairobi
Tuberculosis

Bedaquiline: First new tuberculosis drug in 50 years

Press Release 31 Dec 2012
 
Machar Colony clinic, Karachi
Pakistan

MSF opens new clinic in Karachi

Press Release 27 Dec 2012
 
Kala Azar in Bihar, India
Access to medicines

Medicines shouldn't be a luxury

Project Update 19 Dec 2012
 
Lankien, Jonglei State and Nasir, Upper Nile State, South Sudan,
Neglected diseases

Millions of patients still waiting for medical 'breakthroughs' against neglected diseases

Press Release 13 Dec 2012
 
HAT Screening in CAR
Sleeping sickness

National control activities crippled by lack of funding

Press Release 6 Dec 2012
 
Refugee crisis South Sudan, Upper Nile State, Batil and Doro.
Vaccination

GAVI needs to offer lower vaccine prices to humanitarian actors

Press Release 5 Dec 2012
 
DR TB Treatment in Uzbekistan
Tuberculosis

DR-TB Drugs Under the Microscope: 2nd Edition

Report 13 Nov 2012
 
Kibera South Health Center, Kenya
Tuberculosis

Results from new TB test reveal urgent need to scale up treatment

Press Release 13 Nov 2012
 
DR TB treatment in India
Access to medicines

MSF launches online resource for challenging unwarranted drug patents

Press Release 2 Oct 2012
Up Next
30 August 2019